ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Thanks, Homeslice. If we get the CV patent, I am pretty certain we will see the CVRs honored. Most likely a 50/50 co-promotion in the US and royalties revenues from the rest of the world very similar to other Abbvie (Abbott) deals.

Incidentally I calculated approx. $2.05 per CVR if the $50 million is fully paid out. Didn't we go into the merger with 24,422,240 outstanding shares and 32,814,504 shares being issued to ANI investors?

In the meantime, it will be interesting to see how big a market share Teva will captures. Chatter on the message boards indicate that sales reps are much more fearful of Teva than Perrigo. I also expect that a number of those injecting testosterone, due to the lower cost over Androgel, may convert to a generic transdermal.